GSRX Industries Inc. Share Price Other OTC
Equities
GSRX
US36255V1070
Pharmaceuticals
Sales 2018 | 2.68 223.22 | Sales 2019 | 11 916.03 | Capitalization | 13.42L 11Cr |
---|---|---|---|---|---|
Net income 2018 | -1.6Cr -133.19Cr | Net income 2019 | -3.6Cr -299.67Cr | EV / Sales 2018 | 2,64,86,381 x |
Net cash position 2018 | 13.14L 11Cr | Net Debt 2019 | 22.7L 19Cr | EV / Sales 2019 | 3,28,290 x |
P/E ratio 2018 |
-4.29
x | P/E ratio 2019 |
-0.03
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 13.26% |
Managers | Title | Age | Since |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10/20/10 |
Director of Finance/CFO | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10/20/10 |
Jeff Rogers
BRD | Director/Board Member | 61 | 10/20/10 |
Shaun Dale
BRD | Director/Board Member | 47 | 23/20/23 |
1st Jan change | Capi. | |
---|---|---|
+37.36% | 72TCr | |
+32.22% | 60TCr | |
-1.71% | 36TCr | |
+20.44% | 33TCr | |
+3.65% | 29TCr | |
+16.60% | 24TCr | |
+9.77% | 21TCr | |
-5.15% | 21TCr | |
+8.78% | 17TCr |